We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/6/2015 17:21 | interesting, thanks | rovi69 | |
12/6/2015 14:04 | also, on CDK studies elsewhere: Cyclin-dependent kinase 2 (CDK2) | andrbea | |
12/6/2015 13:46 | 'inhibitors of cyclic-dependent kinase' seem to be heavily researched just now eg giants like Pfizer are behind similar trials : | andrbea | |
10/6/2015 08:30 | hxxp://meetinglibrar Interesting read | impala391 | |
09/6/2015 07:54 | Anyone going to the AGM at end of month as I can't make it? | jpuff | |
04/6/2015 10:09 | regarding 'anti-cancer stem cell agents', here is another company (dd. June 1st) already on phase 1&2 trials. These agents seem relevant to eg pancreatic cancer: | andrbea | |
22/5/2015 15:56 | It must be an interesting field of research, as other firms are working in the same area (anti-cancer stem cell agents): eg (another player): "We are currently exploring the impact of this targeted anti-cancer stem cell agent in our Phase 2 clinical trials." | andrbea | |
21/5/2015 08:46 | Dr Lee Campbell, Research Projects and Science Communications Manager at Cancer Research Wales, who part-fund the study, commented: "This is an exciting breakthrough as cancer stem cells are thought to be responsible for the failure of many cancer treatments and the re-emergence of cancers, often many years after the initial disease. "Therefore the ability to eliminate cancer stem cells from the body offers the opportunity to totally eradicate stubborn and residual disease once and for all. As a charity we are proud to be associated with such ground-breaking research here in Wales and look forward to seeing how these new compounds perform in patients." | andrbea | |
19/5/2015 16:11 | up 6.2% the bounce is on | andrbea | |
18/5/2015 15:42 | Falling back after a good run up. I wonder where the floor is. Probably ran ahead of itself which has spooked out those who have seen such a strong rise. Interesting company it must be said! | mach100 | |
14/5/2015 07:04 | hxxp://www.cardiff.a | impala391 | |
08/5/2015 10:25 | Apologies Twodegrees I mis-interpreted your post. Fingers crossed for both of us now. :) | jpuff | |
08/5/2015 09:21 | jpuff just putting some facts to the gloss...I want it to rise just like you do | twodegrees | |
07/5/2015 22:41 | Lol, try harder | jpuff | |
07/5/2015 21:59 | previously spun off from ADI | twodegrees | |
07/5/2015 21:55 | do not get over excited some of us have to make over £30 a share just to break even as this new formed tils was spun off and in the process many holders had to face a consolidation that wiped out share value... so any improvement is good but long term holders will not be jumping so high for the moment. | twodegrees | |
07/5/2015 17:07 | I like it ;) eom | jpuff | |
07/5/2015 16:36 | still under the radar then :-) up 25% alliance news today trades late on, 2 of 10k and 1 of 23k (in volume) | andrbea | |
07/5/2015 12:56 | brilliant investment and great news today ,i don't know how high this will go but sadly for me i have no more shares left.. and the advantage of a quiet thread. | sos100 | |
07/5/2015 09:25 | Excellent news today All looking good Chart first class | saturn5 | |
07/5/2015 08:55 | an old post (for newcomers): andrbea 30 Jun'14 - 15:04 - 66 of 163 0 0 edit The new contract today is, in essence, all down to the attraction & apppeal of working with TILS' new adviser. This man has know-how that researchers want to draw on. and a history of building multi-dollar companies. eg his CV: For his VEGF discovery, he won a Lasker Award in 2010.[2] In 2013, he was awarded the $3 million Breakthrough Prize in Life Sciences for his work. | andrbea | |
07/5/2015 08:52 | maybe its mkt cap is out of sync with other peer companies (in the US) researching the same thing: cyclin-dependent kinase (CDK) up 8% today | andrbea | |
06/5/2015 15:44 | Nice rise today. After slight pull back off highs looks good to go again - can't buy any electronically. | roper |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions